Add To Cart



Bibliography


Test | Table of Contents

Update


Al Jowf, G. I., Ahmed, Z. T., Reijnders, R. A., de Nijs, L., & Eijssen, L. M. T. (2023). To Predict, Prevent, and Manage Post-Traumatic Stress Disorder (PTSD): A Review of Pathophysiology, Treatment, and Biomarkers. International journal of molecular sciences, 24(6), 5238. https://doi.org/10.3390/ijms24065238

Carlini, B. H., & Schauer, G. L. (2022). Cannabis-only use in the USA: prevalence, demographics, use patterns, and health indicators. Journal of cannabis research, 4(1), 39. https://doi.org/10.1186/s42238-022-00143-y

Connor, J. P., Stjepanović, D., Budney, A. J., Le Foll, B., & Hall, W. D. (2022). Clinical management of cannabis withdrawal. Addiction (Abingdon, England), 117(7), 2075-2095. https://doi.org/10.1111/add.15743

Kaur, N., Bastien, G., Gagnon, L., Graham, J., Mongeau-Pérusse, V., Bakouni, H., Morissette, F., Theriault, C., Fischer, B., & Jutras-Aswad, D. (2022). Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review. Frontiers in psychiatry, 13, 973988. https://doi.org/10.3389/fpsyt.2022.973988

Lathan, E. C., Petri, J. M., Haynes, T., Sonu, S. C., Mekawi, Y., Michopoulos, V., & Powers, A. (2023). Evaluating the Performance of the Primary Care Posttraumatic Stress Disorder Screen for DSM-5 (PC-PTSD-5) in a Trauma-Exposed, Socioeconomically Vulnerable Patient Population. Journal of clinical psychology in medical settings, 1-13. Advance online publication. https://doi.org/10.1007/s10880-023-09941-9

Marchetta, E., Mancini, G. F., Morena, M., & Campolongo, P. (2023). Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs. Current neuropharmacology, 21(3), 687-707. https://doi.org/10.2174/1570159X21666221207162750

Nacasch, N., Avni, C., & Toren, P. (2023). Medical cannabis for treatment-resistant combat PTSD. Frontiers in psychiatry, 13, 1014630. https://doi.org/10.3389/fpsyt.2022.1014630


Peer-Reviewed Journal Article References:

Bedard-Gilligan, M., Garcia, N., Zoellner, L. A., & Feeny, N. C. (2018). Alcohol, cannabis, and other drug use: Engagement and outcome in PTSD treatment. Psychology of Addictive Behaviors, 32(3), 277–288. 

Buckner, J. D., Morris, P. E., & Zvolensky, M. J. (2021). Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use. Experimental and Clinical Psychopharmacology, 29(3), 272–278.

Budney, A. J., Moore, B. A., Vandrey, R. G., & Hughes, J. R. (2003). The time course and significance of cannabis withdrawal. Journal of Abnormal Psychology, 112(3), 393–402.

Carey, C. E., Agrawal, A., Zhang, B., Conley, E. D., Degenhardt, L., Heath, A. C., Li, D., Lynskey, M. T., Martin, N. G., Montgomery, G. W., Wang, T., Bierut, L. J., Hariri, A. R., Nelson, E. C., & Bogdan, R. (2015). Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. Journal of Abnormal Psychology, 124(4), 860–877.
 
da Silveira, P. S., Casela, A. L. M., Monteiro, É. P., Ferreira, G. C. L., de Freitas, J. V. T., Machado, N. M., Noto, A. R., & Ronzani, T. M. (2018). Psychosocial understanding of self-stigma among people who seek treatment for drug addiction. Stigma and Health, 3(1), 42–52. 

Feingold, D. (2020). Working with clients who self-medicate using cannabis: Mind the gap in knowledge. Professional Psychology: Research and Practice, 51(4), 313–316.

Grodin, E. N., Burnette, E., Towns, B., Venegas, A., & Ray, L. A. (2021). Effect of alcohol, tobacco, and cannabis co-use on gray matter Vol. in heavy drinkers. Psychology of Addictive Behaviors, 35(6), 760–768.

Gruber, S. A., Smith, R. T., Dahlgren, M. K., Lambros, A. M., & Sagar, K. A. (2021). No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms. Experimental and Clinical Psychopharmacology, 29(2), 147–156.

Hale, A. C., Bremer-Landau, J., Wright, T. P., McDowell, J. E., & Rodriguez, J. L. (2021). Residential PTSD treatment outcomes during cognitive processing therapy for veterans with and without recent histories of cannabis use. Psychological Services, 18(4), 497–503.

Herrmann, E. S., Weerts, E. M., & Vandrey, R. (2015). Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users. Experimental and Clinical Psychopharmacology, 23(6), 415–421.

Jones, C. B., Hill, M. L., Pardini, D. A., & Meier, M. H. (2016). Prevalence and correlates of vaping cannabis in a sample of young adults. Psychology of Addictive Behaviors, 30(8), 915–921. 

Kevorkian, S., Bonn-Miller, M. O., Belendiuk, K., Carney, D. M., Roberson-Nay, R., & Berenz, E. C. (2015). Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample. Psychology of Addictive Behaviors, 29(3), 633–638.

Lee, D. C., Stanger, C., & Budney, A. J. (2015). A comparison of delay discounting in adolescents and adults in treatment for cannabis use disorders. Experimental and Clinical Psychopharmacology, 23(2), 130–137.

Macatee, R. J., Albanese, B. J., Crane, N. A., Okey, S. A., Cougle, J. R., & Schmidt, N. B. (2018). Distress intolerance moderation of neurophysiological markers of response inhibition after induced stress: Relations with cannabis use disorder. Psychology of Addictive Behaviors, 32(8), 944–955. 

Papini, S., Ruglass, L. M., Lopez-Castro, T., Powers, M. B., Smits, J. A. J., & Hien, D. A. (2017). Chronic cannabis use is associated with impaired fear extinction in humans. Journal of Abnormal Psychology, 126(1), 117–124.

Pearson, M. R. (2019). A meta-analytic investigation of the associations between cannabis use and cannabis-related negative consequences. Psychology of Addictive Behaviors, 33(3), 190–196. 

Pacheco-Colón, I., Limia, J. M., & Gonzalez, R. (2018). Nonacute effects of cannabis use on motivation and reward sensitivity in humans: A systematic review. Psychology of Addictive Behaviors, 32(5), 497–507.

Ridenour, T. A., Halliburton, A. E., & Bray, B. C. (2015). Does DSM-5 nomenclature for inhalant use disorder improve upon DSM-IV? Psychology of Addictive Behaviors, 29(1), 211–217. 

Spradlin, A., Marcus, D. K., & Cuttler, C. (2020). The latent structure of cannabis misuse: A taxometric analysis. Psychological Assessment, 32(8), 803–808.

Stea, J. N., Yakovenko, I., & Hodgins, D. C. (2015). Recovery from cannabis use disorders: Abstinence versus moderation and treatment-assisted recovery versus natural recovery. Psychology of Addictive Behaviors, 29(3), 522–531.

Stuart-Maver, S. L. (2020). Working with clients who self-medicate using cannabis: Ethical and clinical considerations for psychologists. Professional Psychology: Research and Practice, 51(1), 77–84.

Yanes, J. A., McKinnell, Z. E., Reid, M. A., Busler, J. N., Michel, J. S., Pangelinan, M. M., Sutherland, M. T., Younger, J. W., Gonzalez, R., & Robinson, J. L. (2019). Effects of cannabinoid administration for pain: A meta-analysis and meta-regression. Experimental and Clinical Psychopharmacology, 27(4), 370–382.

Additional References:
- Marcel O. Bonn-Miller, Ph.D. Cannabis & PTSD: Existing Evidence and Clinical Considerations. U.S. Department of Veterans Affairs, 2016, p1-65.

- Shannon Nugent, PhD; Maya O’Neil, PhD; Benjamin Morasco, PhD; and Devan Kansagara, MD. The Benefits and Harms of Cannabis Use in Chronic Pain or PTSD: A Systematic Review. VA Portland Health Care System Evidence-based Synthesis Program, p1-49.


Test
Table of Contents
Top